Strength
100 mg/mL
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
00944270006
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
1/1/2025
Active Ingredients
HUMAN IMMUNOGLOBULIN GApproval Type
Biologic (BLA)
FDA Application
BLA125105On Market Since
4/27/2005
Pharmacological Classes
Related Drugs
Same classification